Douglas Adkins, Winston Wong, Jamal Ghazi Misleh, Jochen H. Lorch, Jaspreet Singh Grewal, Kathleen Claire Kerrigan, Jeffery Scott Russell, Jeremy Paul Cetnar, Alan Loh Ho, Kyechin Chen, Judith Dubal Llorin-Sangalang, Kartik Aysola, Jacob Stephen Thomas. "Phase 2 trial of ozuriftamab vedotin (BA3021), a conditionally binding ROR2-ADC, in patients with heavily pretreated squamous cell carcinoma of the head and neck.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6048